Zacks Investment Research
09 Mar 2026, 13:20 UTC · 30w ago
DRAs and Middle East Mix Shift Shape IOSP's FY26 Strategy
Impact · against what's priced in
Innospec (IOSP) faces near-term headwinds as a January winter storm disrupts production and pushes catalysts to the second half of 2026. While the company targets 5-7% revenue growth via Middle East activity and DRA commercialization, the immediate impact is a reset period and lowered expectations for Q1 operating income.
- IOSP−0.20
No priced-in read yet
- In context
The company is facing a first-half 'reset period' due to a January winter storm that caused unrecoverable volumes and curtailed activity, though it targets 5-7% full-year revenue growth driven by DRAs and the Middle East.
Read from the article alone
Search tags
